25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Arch Biopartners Inc
Buy, Hold or Sell?

Let's analyze Arch Biopartners Inc together

I guess you are interested in Arch Biopartners Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Arch Biopartners Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Arch Biopartners Inc

I send you an email if I find something interesting about Arch Biopartners Inc.

Quick analysis of Arch Biopartners Inc (30 sec.)










What can you expect buying and holding a share of Arch Biopartners Inc? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$-0.10
Expected worth in 1 year
C$-0.12
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
C$-0.02
Return On Investment
-1.0%

For what price can you sell your share?

Current Price per Share
C$1.57
Expected price per share
C$1.56 - C$1.62
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Arch Biopartners Inc (5 min.)




Live pricePrice per Share (EOD)

C$1.57

Intrinsic Value Per Share

C$-0.33 - C$0.36

Total Value Per Share

C$-0.43 - C$0.26

2. Growth of Arch Biopartners Inc (5 min.)




Is Arch Biopartners Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$4.6m-$3.3m-$924.6k-21.7%

How much money is Arch Biopartners Inc making?

Current yearPrevious yearGrowGrow %
Making money-$390k-$633k$242.9k62.3%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Arch Biopartners Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#885 / 982

Most Revenue
#892 / 982

Most Profit
#189 / 982

Most Efficient
#242 / 982
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Arch Biopartners Inc? (5 min.)

Welcome investor! Arch Biopartners Inc's management wants to use your money to grow the business. In return you get a share of Arch Biopartners Inc.

What can you expect buying and holding a share of Arch Biopartners Inc?

First you should know what it really means to hold a share of Arch Biopartners Inc. And how you can make/lose money.

Speculation

The Price per Share of Arch Biopartners Inc is C$1.57. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Arch Biopartners Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Arch Biopartners Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$-0.10. Based on the TTM, the Book Value Change Per Share is C$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is C$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Arch Biopartners Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps-0.01-0.8%-0.01-0.4%-0.01-0.7%-0.01-0.5%-0.01-0.4%
Usd Book Value Change Per Share-0.01-0.5%0.00-0.2%0.00-0.3%0.00-0.2%0.00-0.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-0.5%0.00-0.2%0.00-0.3%0.00-0.2%0.00-0.1%
Usd Price Per Share1.63-1.24-2.02-1.40-0.91-
Price to Earnings Ratio-31.13--15.13--87.12--64.18--46.01-
Price-to-Total Gains Ratio-198.08--192.93-25,483.69-3,669.36-1,696.40-
Price to Book Ratio-22.23--18.37--39.51--29.09-29.36-
Price-to-Total Gains Ratio-198.08--192.93-25,483.69-3,669.36-1,696.40-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.145629
Number of shares872
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (872 shares)-2.50-2.08
Gains per Year (872 shares)-10.00-8.30
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-10-200-8-18
20-20-300-17-26
30-30-400-25-34
40-40-500-33-42
50-50-600-42-50
60-60-700-50-58
70-70-800-58-66
80-80-900-66-74
90-90-1000-75-82
100-100-1100-83-90

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%3.09.00.025.0%3.017.00.015.0%3.037.00.07.5%7.097.00.06.7%
Book Value Change Per Share1.03.00.025.0%5.07.00.041.7%7.013.00.035.0%12.028.00.030.0%33.064.07.031.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0104.00.0%
Total Gains per Share1.03.00.025.0%5.07.00.041.7%7.013.00.035.0%12.028.00.030.0%33.064.07.031.7%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Arch Biopartners Inc

About Arch Biopartners Inc

Arch Biopartners Inc., together with its subsidiaries, engages in the development of therapeutic drugs for inflammation and acute organ injuries in Canada. It focuses on developing its lead drug candidate LSALT Peptide, a product in Phase 2 clinical trials to treat dipeptidase-1 mediated organ inflammation in the lungs, liver, and kidneys. The company also develops AB569 for treating antibiotic-resistant bacterial infections, and for the treatment of wounds; and Borg, a peptide-solid surface interface to reduce corrosion of metals. Arch Biopartners Inc. is based in Toronto, Canada.

Fundamental data was last updated by Penke on 2024-07-11 07:38:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Arch Biopartners Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Arch Biopartners Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Arch Biopartners Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Arch Biopartners Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-401.7%+401.7%
5Y-401.7%10Y-8,726.9%+8,325.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--169.1%+169.1%
TTM--209.9%+209.9%
YOY--234.9%+234.9%
5Y-401.7%-392.9%-8.8%
10Y-8,726.9%-512.4%-8,214.5%
1.1.2. Return on Assets

Shows how efficient Arch Biopartners Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Arch Biopartners Inc to the Biotechnology industry mean.
  • -64.2% Return on Assets means that Arch Biopartners Inc generated $-0.64 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Arch Biopartners Inc:

  • The MRQ is -64.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -49.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-64.2%TTM-49.6%-14.6%
TTM-49.6%YOY-93.7%+44.2%
TTM-49.6%5Y-104.6%+55.1%
5Y-104.6%10Y-203.2%+98.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-64.2%-11.8%-52.4%
TTM-49.6%-11.9%-37.7%
YOY-93.7%-11.2%-82.5%
5Y-104.6%-13.3%-91.3%
10Y-203.2%-14.7%-188.5%
1.1.3. Return on Equity

Shows how efficient Arch Biopartners Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Arch Biopartners Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Arch Biopartners Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Arch Biopartners Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y1,113.5%-1,113.5%
5Y1,113.5%10Y453.0%+660.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.1%+14.1%
TTM--15.2%+15.2%
YOY--14.0%+14.0%
5Y1,113.5%-18.8%+1,132.3%
10Y453.0%-19.4%+472.4%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Arch Biopartners Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Arch Biopartners Inc is operating .

  • Measures how much profit Arch Biopartners Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Arch Biopartners Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Arch Biopartners Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-407.5%+407.5%
5Y-407.5%10Y-11,319.8%+10,912.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--346.7%+346.7%
TTM--218.9%+218.9%
YOY--238.4%+238.4%
5Y-407.5%-400.7%-6.8%
10Y-11,319.8%-514.0%-10,805.8%
1.2.2. Operating Ratio

Measures how efficient Arch Biopartners Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Arch Biopartners Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y5.741-5.741
5Y5.74110Y110.095-104.354
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.003-3.003
TTM-3.247-3.247
YOY-3.454-3.454
5Y5.7415.124+0.617
10Y110.0956.570+103.525
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Arch Biopartners Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Arch Biopartners Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.23 means the company has $0.23 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Arch Biopartners Inc:

  • The MRQ is 0.232. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.217. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.232TTM0.217+0.015
TTM0.217YOY0.441-0.225
TTM0.2175Y0.695-0.478
5Y0.69510Y1.690-0.995
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2323.793-3.561
TTM0.2174.066-3.849
YOY0.4414.958-4.517
5Y0.6955.996-5.301
10Y1.6906.335-4.645
1.3.2. Quick Ratio

Measures if Arch Biopartners Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Arch Biopartners Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.18 means the company can pay off $0.18 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Arch Biopartners Inc:

  • The MRQ is 0.179. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.234. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.179TTM0.234-0.055
TTM0.234YOY0.432-0.198
TTM0.2345Y0.645-0.410
5Y0.64510Y1.655-1.010
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1793.192-3.013
TTM0.2343.581-3.347
YOY0.4324.835-4.403
5Y0.6455.948-5.303
10Y1.6556.457-4.802
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Arch Biopartners Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Arch Biopartners Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Arch Biopartners Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 4.60 means that Arch Biopartners Inc assets are financed with 459.6% credit (debt) and the remaining percentage (100% - 459.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Arch Biopartners Inc:

  • The MRQ is 4.596. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 6.335. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ4.596TTM6.335-1.738
TTM6.335YOY5.259+1.076
TTM6.3355Y7.787-1.452
5Y7.78710Y5.852+1.935
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5960.328+4.268
TTM6.3350.339+5.996
YOY5.2590.286+4.973
5Y7.7870.367+7.420
10Y5.8520.383+5.469
1.4.2. Debt to Equity Ratio

Measures if Arch Biopartners Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Arch Biopartners Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Arch Biopartners Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y77.146-77.146
5Y77.14610Y41.697+35.448
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.363-0.363
TTM-0.412-0.412
YOY-0.367-0.367
5Y77.1460.438+76.708
10Y41.6970.476+41.221
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Arch Biopartners Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Arch Biopartners Inc generates.

  • Above 15 is considered overpriced but always compare Arch Biopartners Inc to the Biotechnology industry mean.
  • A PE ratio of -31.13 means the investor is paying $-31.13 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Arch Biopartners Inc:

  • The EOD is -21.821. Based on the earnings, the company is expensive. -2
  • The MRQ is -31.133. Based on the earnings, the company is expensive. -2
  • The TTM is -15.134. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-21.821MRQ-31.133+9.312
MRQ-31.133TTM-15.134-15.998
TTM-15.134YOY-87.122+71.988
TTM-15.1345Y-64.178+49.044
5Y-64.17810Y-46.007-18.172
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-21.821-2.652-19.169
MRQ-31.133-3.015-28.118
TTM-15.134-2.881-12.253
YOY-87.122-3.574-83.548
5Y-64.178-6.225-57.953
10Y-46.007-6.348-39.659
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Arch Biopartners Inc:

  • The EOD is -48.989. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -69.895. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -29.140. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-48.989MRQ-69.895+20.906
MRQ-69.895TTM-29.140-40.755
TTM-29.140YOY-110.687+81.548
TTM-29.1405Y-84.729+55.589
5Y-84.72910Y-55.714-29.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-48.989-3.251-45.738
MRQ-69.895-3.787-66.108
TTM-29.140-3.794-25.346
YOY-110.687-5.044-105.643
5Y-84.729-8.020-76.709
10Y-55.714-8.669-47.045
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Arch Biopartners Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -22.23 means the investor is paying $-22.23 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Arch Biopartners Inc:

  • The EOD is -15.578. Based on the equity, the company is expensive. -2
  • The MRQ is -22.226. Based on the equity, the company is expensive. -2
  • The TTM is -18.370. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.578MRQ-22.226+6.648
MRQ-22.226TTM-18.370-3.856
TTM-18.370YOY-39.511+21.141
TTM-18.3705Y-29.092+10.722
5Y-29.09210Y29.363-58.455
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-15.5781.991-17.569
MRQ-22.2262.271-24.497
TTM-18.3702.296-20.666
YOY-39.5112.385-41.896
5Y-29.0923.670-32.762
10Y29.3634.162+25.201
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Arch Biopartners Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.011-0.004-65%-0.006-47%-0.003-71%-0.002-78%
Book Value Per Share---0.101-0.092-9%-0.072-29%-0.069-32%-0.038-63%
Current Ratio--0.2320.217+7%0.441-48%0.695-67%1.690-86%
Debt To Asset Ratio--4.5966.335-27%5.259-13%7.787-41%5.852-21%
Debt To Equity Ratio----0%-0%77.146-100%41.697-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.018-0.008-53%-0.015-16%-0.011-41%-0.009-52%
Free Cash Flow Per Share---0.0080.000-98%-0.014+70%-0.009+7%-0.008-5%
Free Cash Flow To Equity Per Share---0.0050.002-295%-0.012+155%-0.004-22%-0.003-32%
Gross Profit Margin--1.0001.0000%1.0030%1.015-1%1.034-3%
Intrinsic Value_10Y_max--0.361--------
Intrinsic Value_10Y_min---0.329--------
Intrinsic Value_1Y_max---0.006--------
Intrinsic Value_1Y_min---0.031--------
Intrinsic Value_3Y_max--0.014--------
Intrinsic Value_3Y_min---0.096--------
Intrinsic Value_5Y_max--0.073--------
Intrinsic Value_5Y_min---0.162--------
Market Cap100245442.000-43%143025344.000108546020.000+32%177025788.500-19%122477904.720+17%79747645.035+79%
Net Profit Margin----0%-0%-4.0170%-87.2690%
Operating Margin----0%-0%-4.0750%-113.1980%
Operating Ratio----0%-0%5.741-100%110.095-100%
Pb Ratio-15.578+30%-22.226-18.370-17%-39.511+78%-29.092+31%29.363-176%
Pe Ratio-21.821+30%-31.133-15.134-51%-87.122+180%-64.178+106%-46.007+48%
Price Per Share1.570-43%2.2401.700+32%2.773-19%1.915+17%1.247+80%
Price To Free Cash Flow Ratio-48.989+30%-69.895-29.140-58%-110.687+58%-84.729+21%-55.714-20%
Price To Total Gains Ratio-138.833+30%-198.080-192.933-3%25483.695-101%3669.357-105%1696.396-112%
Quick Ratio--0.1790.234-24%0.432-59%0.645-72%1.655-89%
Return On Assets---0.642-0.496-23%-0.937+46%-1.046+63%-2.032+217%
Return On Equity----0%-0%11.135-100%4.530-100%
Total Gains Per Share---0.011-0.004-65%-0.006-47%-0.003-71%-0.002-78%
Usd Book Value---4695722.388-4270960.369-9%-3346293.103-29%-3224023.258-31%-1765211.651-62%
Usd Book Value Change Per Share---0.008-0.003-65%-0.004-47%-0.002-71%-0.002-78%
Usd Book Value Per Share---0.074-0.067-9%-0.052-29%-0.050-32%-0.028-63%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.013-0.006-53%-0.011-16%-0.008-41%-0.006-52%
Usd Free Cash Flow---373295.548-6506.552-98%-633008.730+70%-396750.368+6%-354879.379-5%
Usd Free Cash Flow Per Share---0.0060.000-98%-0.010+70%-0.006+7%-0.006-5%
Usd Free Cash Flow To Equity Per Share---0.0030.002-295%-0.009+155%-0.003-22%-0.002-32%
Usd Market Cap73149099.027-43%104365593.51779206030.794+32%129175717.868-19%89372127.074+17%58191856.582+79%
Usd Price Per Share1.146-43%1.6351.240+32%2.023-19%1.397+17%0.910+80%
Usd Profit---838073.585-390073.540-53%-633008.730-24%-476204.154-43%-394606.272-53%
Usd Revenue----0%-0%6671.209-100%4954.918-100%
Usd Total Gains Per Share---0.008-0.003-65%-0.004-47%-0.002-71%-0.002-78%
 EOD+2 -6MRQTTM+8 -20YOY+8 -205Y+10 -2210Y+9 -23

3.2. Fundamental Score

Let's check the fundamental score of Arch Biopartners Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-21.821
Price to Book Ratio (EOD)Between0-1-15.578
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.179
Current Ratio (MRQ)Greater than10.232
Debt to Asset Ratio (MRQ)Less than14.596
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.642
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Arch Biopartners Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.346
Ma 20Greater thanMa 501.641
Ma 50Greater thanMa 1001.674
Ma 100Greater thanMa 2001.877
OpenGreater thanClose1.600
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets1,789
Total Liabilities8,224
Total Stockholder Equity-6,435
 As reported
Total Liabilities 8,224
Total Stockholder Equity+ -6,435
Total Assets = 1,789

Assets

Total Assets1,789
Total Current Assets1,789
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 7
Net Receivables 1,384
Total Current Assets  (as reported)1,789
Total Current Assets  (calculated)1,390
+/- 399
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,724
Long-term Liabilities500
Total Stockholder Equity-6,435
Total Current Liabilities
Short Long Term Debt 4,456
Accounts payable 3,017
Total Current Liabilities  (as reported)7,724
Total Current Liabilities  (calculated)7,473
+/- 251
Long-term Liabilities
Long term Debt 500
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)500
Long-term Liabilities  (calculated)500
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)-6,435
Total Stockholder Equity (calculated)0
+/- 6,435
Other
Capital Stock16,055
Common Stock Shares Outstanding 62,756
Net Debt 4,949
Net Invested Capital -1,480
Net Working Capital -5,935



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-31
> Total Assets 
343
315
379
187
0
0
0
1,265
0
0
0
2,365
2,308
2,070
0
71
178
157
152
59
64
92
68
1,638
1,823
2,283
2,304
1,376
1,068
881
1,098
1,157
687
784
832
953
799
766
1,259
960
1,407
1,532
2,790
797
892
1
12
2
0
671
535
487
374
314
222
138
93
155
94
37
16
12
37
39
295
201
406
301
905
736
650
474
300
448
227
85
297
34
68
220
1,384
1,387
673
370
157
962
568
104
648
1,808
741
742
362
0
2,668
1,515
2,002
1,848
622
718
3,693
1,416
1,171
636
1,789
1,7896361,1711,4163,6937186221,8482,0021,5152,66803627427411,8086481045689621573706731,3871,38422068342978522744830047465073690530140620129539371216379415593138222314374487535671021218927972,7901,5321,4079601,2597667999538327846871,1571,0988811,0681,3762,3042,2831,8231,638689264591521571787102,0702,3082,3650001,265000187379315343
   > Total Current Assets 
8
52
45
14
0
0
0
51
0
0
0
101
75
49
0
26
42
23
20
24
33
64
43
894
737
1,209
1,285
859
445
383
916
837
375
480
505
504
287
361
1,048
526
775
973
2,346
552
698
1
12
2
0
640
517
469
352
302
211
138
93
155
94
37
16
12
37
39
295
201
406
301
905
736
650
474
300
448
227
85
297
34
68
220
1,384
1,387
673
370
157
962
568
104
648
1,808
741
742
362
2,701
2,668
1,515
2,002
1,848
622
718
3,693
1,416
1,171
636
1,789
1,7896361,1711,4163,6937186221,8482,0021,5152,6682,7013627427411,8086481045689621573706731,3871,38422068342978522744830047465073690530140620129539371216379415593138211302352469517640021216985522,3469737755261,0483612875045054803758379163834458591,2851,209737894436433242023422604975101000510001445528
       Cash And Cash Equivalents 
0
7
3
0
0
0
0
0
0
0
0
70
49
23
0
2
24
3
0
0
0
25
0
-42
-41
-36
-4
24
27
10
36
0
0
100
52
12
3
6
4
2
1
3
1
2
0
1
12
2
0
640
506
464
350
300
206
135
93
144
72
24
6
3
26
3
271
185
365
245
874
712
621
437
276
422
200
57
281
18
43
171
1,321
1,306
544
247
73
859
400
43
223
1,380
654
585
125
0
448
708
734
586
506
160
708
1,397
831
303
7
73038311,39770816050658673470844801255856541,38022343400859732475441,3061,321171431828157200422276437621712874245365185271326362472144931352063003504645066400212102131246312521000036102724-4-36-41-420250003242023497000000000370
       Short-term Investments 
0
0
0
0
0
0
0
45
0
0
0
12
19
7
0
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
817
0
0
00817000000000000000000001111111100000000000000000000000000000000000000000000000000000000005071912000450000000
       Net Receivables 
0
37
37
0
0
0
0
0
0
0
0
0
0
19
0
10
0
0
20
0
0
0
21
573
331
482
530
735
410
362
847
737
210
322
374
309
232
351
229
241
224
597
2,078
182
402
0
0
0
0
0
0
0
0
0
0
0
0
12
17
10
10
9
11
11
24
17
41
55
31
24
28
37
18
22
26
28
11
13
16
42
50
69
109
110
69
92
140
42
113
67
61
138
223
2,632
2,201
795
1,213
1,221
87
535
2,973
12
297
309
1,384
1,384309297122,973535871,2211,2137952,2012,632223138616711342140926911010969504216131128262218372824315541172411119101017120000000000004021822,07859722424122935123230937432221073784736241073553048233157321000200010019000000000037370
       Other Current Assets 
8
8
4
14
0
0
0
6
0
0
0
18
7
0
0
0
0
0
0
24
33
39
22
51
50
188
119
52
3
0
5
55
64
2
1
19
0
1
250
67
114
106
106
77
76
0
0
0
0
0
11
5
2
2
5
3
0
0
5
3
0
0
0
25
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
13
12
19
13
15
12
28
18
293
345
27
20
13
366
19
11
55
41
28
24
11
7
43
25
0
0254371124284155111936613202734529318281215131912131111111111000000250003500352251100000767710610611467250101912645550352119188505122393324000000718000600014488
   > Long-term Assets 
334
262
334
173
0
0
0
1,214
0
0
0
2,264
2,232
2,021
0
45
136
134
132
35
31
27
25
744
1,085
1,074
1,019
517
623
498
182
320
312
304
327
450
512
405
211
434
632
559
444
245
194
0
0
0
0
31
18
18
22
12
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000011122218183100001942454445596324342114055124503273043123201824986235171,0191,0741,085744252731351321341364502,0212,2322,2640001,214000173334262334
       Property Plant Equipment 
11
11
11
29
0
0
0
536
0
0
0
88
84
79
0
44
42
40
37
35
31
27
25
156
167
156
101
148
140
187
142
140
131
125
116
118
113
102
94
181
187
169
142
147
128
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000000128147142169187181941021131181161251311401421871401481011561671562527313537404244079848800053600029111111
       Intangible Assets 
41
41
41
37
0
0
0
18
0
0
0
983
955
928
0
0
0
0
0
0
0
0
0
433
794
794
794
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31
14
0
0
0
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000011000143100000000000000000000007947947944330000000009289559830001800037414141
       Long-term Assets Other 
282
210
282
106
0
0
0
659
0
0
0
1,193
1,193
1,014
0
1
94
94
94
0
0
0
0
144
124
124
124
369
483
311
40
181
181
179
211
332
399
303
117
254
444
390
302
99
66
0
0
0
0
0
4
5
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000954000006699302390444254117303399332211179181181403114833691241241241440000949494101,0141,1931,193000659000106282210282
> Total Liabilities 
364
340
370
316
0
0
0
205
0
0
0
320
304
301
0
230
96
157
169
42
123
78
151
1,565
1,433
1,870
2,265
2,015
1,846
1,785
1,867
2,045
1,603
1,600
1,631
1,598
1,555
1,518
2,057
1,974
2,676
2,965
4,152
2,572
2,070
232
259
348
370
426
370
433
397
397
397
411
426
418
449
425
464
478
462
517
447
484
412
459
416
412
508
470
491
494
484
578
547
562
631
1,126
1,638
1,661
1,718
2,202
2,427
3,235
3,470
3,607
4,044
4,415
4,609
5,533
6,078
0
6,551
5,559
5,912
5,820
5,092
5,187
9,124
7,171
6,681
6,350
8,224
8,2246,3506,6817,1719,1245,1875,0925,8205,9125,5596,55106,0785,5334,6094,4154,0443,6073,4703,2352,4272,2021,7181,6611,6381,1266315625475784844944914705084124164594124844475174624784644254494184264113973973974333704263703482592322,0702,5724,1522,9652,6761,9742,0571,5181,5551,5981,6311,6001,6032,0451,8671,7851,8462,0152,2651,8701,4331,5651517812342169157962300301304320000205000316370340364
   > Total Current Liabilities 
364
340
370
316
0
0
0
205
0
0
0
320
304
301
0
230
96
157
169
42
123
78
151
1,464
1,337
1,585
2,059
2,007
1,841
1,781
1,867
2,043
1,602
1,599
1,630
1,598
1,555
1,518
2,057
1,974
2,676
2,965
4,152
2,572
2,070
232
259
348
370
426
27
433
397
397
397
411
426
418
449
425
464
478
462
517
447
484
412
459
99
90
180
137
153
161
154
243
213
242
282
276
188
197
235
756
487
290
585
717
651
1,017
1,219
2,142
2,687
4,131
3,189
2,198
2,551
2,460
2,779
2,896
6,808
4,292
5,977
5,850
7,724
7,7245,8505,9774,2926,8082,8962,7792,4602,5512,1983,1894,1312,6872,1421,2191,0176517175852904877562351971882762822422132431541611531371809099459412484447517462478464425449418426411397397397433274263703482592322,0702,5724,1522,9652,6761,9742,0571,5181,5551,5981,6301,5991,6022,0431,8671,7811,8412,0072,0591,5851,3371,4641517812342169157962300301304320000205000316370340364
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
118
0
50
50
0
0
0
0
469
691
922
958
1,144
1,041
921
1,083
1,057
993
1,028
1,115
940
956
1,001
1,732
1,353
1,983
2,342
3,152
1,643
1,189
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
396
25
0
368
0
0
0
0
0
0
338
0
330
334
334
320
349
850
1,450
1,464
0
0
0
0
0
0
0
0
0
0
0
0
1,802
1,024
1,002
1,027
2,100
2,100
3,606
2,100
4,312
4,537
0
04,5374,3122,1003,6062,1002,1001,0271,0021,0241,8020000000000001,4641,4508503493203343343300338000000368025396000000000000000001,1891,6433,1522,3421,9831,3531,7321,0019569401,1151,0289931,0571,0839211,0411,144958922691469000050500118000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
330
334
334
320
349
850
1,450
1,464
0
0
0
0
0
0
0
0
0
0
0
0
1,802
1,024
1,002
1,027
2,100
2,100
3,606
2,100
4,312
4,537
4,456
4,4564,5374,3122,1003,6062,1002,1001,0271,0021,0241,8020000000000001,4641,45085034932033433433000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
342
329
348
316
0
0
0
205
0
0
0
320
304
301
0
112
46
107
119
29
83
40
90
790
511
401
829
789
647
631
630
615
278
344
364
361
385
336
197
501
465
332
680
0
0
198
238
0
0
0
0
0
0
353
357
0
63
51
78
50
87
88
66
93
61
116
59
132
99
90
180
137
0
0
154
243
159
242
274
268
188
197
227
714
434
212
474
574
461
792
949
1,833
2,339
1,494
962
711
1,472
1,317
489
768
3,137
2,088
393
301
3,017
3,0173013932,0883,1377684891,3171,4727119621,4942,3391,8339497924615744742124347142271971882682742421592431540013718090991325911661936688875078516303573530000002381980068033246550119733638536136434427861563063164778982940151179090408329119107461120301304320000205000316348329342
       Other Current Liabilities 
22
12
22
0
0
0
0
0
0
0
0
0
0
0
0
0
50
0
0
13
40
38
62
205
135
263
272
73
153
230
155
371
330
228
151
297
215
181
128
120
228
291
320
929
880
34
21
348
370
426
27
433
397
43
40
411
363
366
371
374
377
391
0
399
386
0
353
326
0
0
0
0
-185
161
-176
0
213
0
-68
276
188
0
235
756
487
290
111
143
190
225
270
309
347
0
425
464
77
116
190
28
66
104
173
212
0
021217310466281901167746442503473092702251901431112904877562350188276-6802130-176161-1850000326353038639903913773743713663634114043397433274263703482134880929320291228120128181215297151228330371155230153732722631352056238401300500000000000000221222
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
101
95
285
206
9
5
4
0
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
343
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
317
322
328
333
338
333
330
334
334
320
349
850
1,450
1,464
1,483
1,445
1,940
2,945
2,885
2,889
3,394
3,398
3,390
3,391
3,391
0
3,362
3,361
3,361
3,361
2,313
2,291
2,316
2,878
704
500
500
5005007042,8782,3162,2912,3133,3613,3613,3613,36203,3913,3913,3903,3983,3942,8892,8852,9451,9401,4451,4831,4641,45085034932033433433033333833332832231700000000000000000343000000000000000222204592062859510100000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
249
251
246
279
275
260
0
0
0
0
0
0
289
0
0
0
0
0
0
0
0
0
0
0
0
214
0
0
0
0
0000214000000000000289000000260275279246251249000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
-21
-26
9
-129
0
0
0
1,060
0
0
0
2,045
2,004
1,768
0
-159
82
0
-17
17
-59
14
-84
73
390
412
40
-639
-778
-903
-769
-887
-916
-816
-799
-644
-756
-752
-797
-1,013
-1,269
-1,432
-1,362
-1,775
-1,177
-231
-247
-346
-370
245
165
54
-23
-83
-175
-273
-333
-262
-355
-388
-448
-466
-425
-478
-152
-283
-7
-158
489
325
141
4
-191
-47
-257
-492
-250
-528
-563
-905
-254
-275
-1,046
-1,832
-2,270
-2,273
-2,902
-3,503
-3,396
-2,608
-3,868
-4,791
-5,716
0
-3,882
-4,045
-3,910
-3,973
-4,471
-4,469
-5,431
-5,754
-5,510
-5,713
-6,435
-6,435-5,713-5,510-5,754-5,431-4,469-4,471-3,973-3,910-4,045-3,8820-5,716-4,791-3,868-2,608-3,396-3,503-2,902-2,273-2,270-1,832-1,046-275-254-905-563-528-250-492-257-47-1914141325489-158-7-283-152-478-425-466-448-388-355-262-333-273-175-83-2354165245-370-346-247-231-1,177-1,775-1,362-1,432-1,269-1,013-797-752-756-644-799-816-916-887-769-903-778-6394041239073-8414-5917-17082-15901,7682,0042,0450001,060000-1299-26-21
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
861
861
13,259
13,269
13,269
13,269
7,477
7,477
7,477
7,477
7,477
7,477
7,477
7,477
7,637
7,637
7,637
7,657
7,657
7,757
7,757
8,142
8,142
8,517
8,517
9,330
9,330
9,292
9,292
9,292
9,619
9,619
9,619
10,016
10,016
10,223
10,223
11,459
11,791
11,806
11,838
11,877
11,902
12,027
12,177
12,353
13,713
13,713
14,358
14,485
14,485
14,758
14,758
15,368
15,553
15,553
15,755
15,755
15,883
15,883
15,883
0
015,88315,88315,88315,75515,75515,55315,55315,36814,75814,75814,48514,48514,35813,71313,71312,35312,17712,02711,90211,87711,83811,80611,79111,45910,22310,22310,01610,0169,6199,6199,6199,2929,2929,2929,3309,3308,5178,5178,1428,1427,7577,7577,6577,6577,6377,6377,6377,4777,4777,4777,4777,4777,4777,4777,47713,26913,26913,26913,2598618610000000000000000000000000000000000000000000
   Retained Earnings -29,983-28,834-28,051-28,295-27,844-26,882-24,724-24,226-23,979-23,491-23,316-23,969-24,852-23,799-22,147-20,802-18,611-18,516-17,783-16,991-16,940-16,426-15,608-14,822-13,335-12,751-12,410-12,167-10,872-10,718-10,482-10,138-9,955-9,632-9,476-9,330-9,164-8,996-8,637-8,538-8,407-8,348-8,295-8,236-8,218-8,138-8,105-8,012-7,923-7,863-7,765-7,673-7,499-7,423-7,312-7,232-14,497-14,473-14,375-14,348-2,774-3,324-3,040-3,027-2,852-2,666-2,460-2,405-2,371-2,305-2,503-2,444-2,395-2,287-2,101-2,231-2,090-1,918-1,114-741-764-640-8,780-8,682-8,667-8,591-8,458-8,441-8,359-8,2870-6,165-5,929-5,888000-4,824000-4,065-3,540-3,501-3,430
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
3,408
3,475
3,550
3,936
0
0
0
5,884
0
0
0
7,933
7,933
7,933
0
8,127
8,441
8,441
8,441
8,608
8,608
8,696
8,696
712
1,152
1,152
1,152
1,313
1,313
1,313
1,313
1,309
1,410
1,560
1,631
1,631
1,631
1,631
1,631
1,631
1,675
1,675
1,675
860
860
858
858
858
858
0
0
0
0
113
113
113
113
113
113
113
113
113
113
113
113
113
113
321
322
324
325
344
472
472
606
606
606
1,623
1,623
1,623
1,623
2,756
2,756
2,756
2,792
2,816
2,854
2,835
2,862
4,481
4,566
4,651
4,651
0
4,676
4,688
4,701
4,701
4,701
6,659
6,659
6,659
6,659
7,239
0
07,2396,6596,6596,6596,6594,7014,7014,7014,6884,67604,6514,6514,5664,4812,8622,8352,8542,8162,7922,7562,7562,7561,6231,6231,6231,62360660660647247234432532432232111311311311311311311311311311311311311311300008588588588588608601,6751,6751,6751,6311,6311,6311,6311,6311,6311,5601,4101,3091,3131,3131,3131,3131,1521,1521,1527128,6968,6968,6088,6088,4418,4418,4418,12707,9337,9337,9330005,8840003,9363,5503,4753,408



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-5,244
Operating Income-5,244-5,244
 
Operating Expense (+$)
Research Development2,205
Selling General Administrative2,729
Selling And Marketing Expenses0
Operating Expense5,2444,933
 
Net Interest Income (+$)
Interest Income17
Interest Expense-359
Other Finance Cost-0
Net Interest Income-342
 
Pretax Income (+$)
Operating Income-5,244
Net Interest Income-342
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,591-6,897
EBIT - interestExpense = -359
-3,591
-2,968
Interest Expense359
Earnings Before Interest and Taxes (EBIT)0-3,232
Earnings Before Interest and Taxes (EBITDA)-5,244
 
After tax Income (+$)
Income Before Tax-3,591
Tax Provision-0
Net Income From Continuing Ops-3,327-3,591
Net Income-3,327
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses5,244
Total Other Income/Expenses Net1,653342
 

Technical Analysis of Arch Biopartners Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Arch Biopartners Inc. The general trend of Arch Biopartners Inc is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Arch Biopartners Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Arch Biopartners Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.6 < 1.62 < 1.62.

The bearish price targets are: 1.6 > 1.6 > 1.56.

Tweet this
Arch Biopartners Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Arch Biopartners Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Arch Biopartners Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Arch Biopartners Inc. The current macd is -0.03256005.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Arch Biopartners Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Arch Biopartners Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Arch Biopartners Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Arch Biopartners Inc Daily Moving Average Convergence/Divergence (MACD) ChartArch Biopartners Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Arch Biopartners Inc. The current adx is 42.10.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Arch Biopartners Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Arch Biopartners Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Arch Biopartners Inc. The current sar is 1.67269197.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Arch Biopartners Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Arch Biopartners Inc. The current rsi is 34.35. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Arch Biopartners Inc Daily Relative Strength Index (RSI) ChartArch Biopartners Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Arch Biopartners Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Arch Biopartners Inc price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Arch Biopartners Inc Daily Stochastic Oscillator ChartArch Biopartners Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Arch Biopartners Inc. The current cci is -161.93999178.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Arch Biopartners Inc Daily Commodity Channel Index (CCI) ChartArch Biopartners Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Arch Biopartners Inc. The current cmo is -39.81371764.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Arch Biopartners Inc Daily Chande Momentum Oscillator (CMO) ChartArch Biopartners Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Arch Biopartners Inc. The current willr is -81.25.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Arch Biopartners Inc Daily Williams %R ChartArch Biopartners Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Arch Biopartners Inc.

Arch Biopartners Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Arch Biopartners Inc. The current atr is 0.052311.

Arch Biopartners Inc Daily Average True Range (ATR) ChartArch Biopartners Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Arch Biopartners Inc. The current obv is -294,985.

Arch Biopartners Inc Daily On-Balance Volume (OBV) ChartArch Biopartners Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Arch Biopartners Inc. The current mfi is 16.23.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Arch Biopartners Inc Daily Money Flow Index (MFI) ChartArch Biopartners Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Arch Biopartners Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-05-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-05-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-05-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Arch Biopartners Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Arch Biopartners Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.346
Ma 20Greater thanMa 501.641
Ma 50Greater thanMa 1001.674
Ma 100Greater thanMa 2001.877
OpenGreater thanClose1.600
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Arch Biopartners Inc with someone you think should read this too:
  • Are you bullish or bearish on Arch Biopartners Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Arch Biopartners Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Arch Biopartners Inc

I send you an email if I find something interesting about Arch Biopartners Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Arch Biopartners Inc.

Receive notifications about Arch Biopartners Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.